Black Friday is Now! Don’t miss out on up to 60% OFF InvestingProCLAIM SALE

$1M Bet On This Healthcare Stock? Check Out These 4 Stocks Insiders Are Buying

Published 10/02/2023, 14:15
Updated 10/02/2023, 15:40
© Reuters.  $1M Bet On This Healthcare Stock? Check Out These 4 Stocks Insiders Are Buying
IXIC
-
ALGN
-
CMPR
-
CNC
-
RILY
-
RILYL
-
EOSE
-
C1NC34
-
RILYN
-

Benzinga - Although US stocks closed lower on Thursday, there were a few notable insider trades.

When insiders purchase shares, it indicates their confidence in the company's prospects or that they view the stock as a bargain. Either way, this signals an opportunity to go long on the stock. Insider purchases should not be taken as the only indicator for making an investment or trading decision. At best, it can lend conviction to a buying decision.

Below is a look at a few recent notable insider purchases. For more, check out Benzinga's insider transactions platform.

Align Technology

  • The Trade: Align Technology, Inc. (NASDAQ: ALGN) President and CEO Joseph Hogan acquired a total of 2,928 shares an average price of $341.50. To acquire these shares, it cost around $1 million.
  • What’s Happening: Align Technology recently announced a $250 million buyback program..
  • What Align Technology Does: Align Technology is the leading manufacturer of clear aligners.

Cimpress

  • The Trade: Cimpress plc (NASDAQ: CMPR) Director, CEO, Chairman Robert Keane acquired a total of 22,179 shares at an average price of $39.08. To acquire these shares, it cost around $866.67 thousand.
  • What’s Happening: Cimpress recently reported worse-than-expected Q2 sales results.
  • What Cimpress Does: Cimpress PLC invests in and builds customer-focused, entrepreneurial, mass-customization businesses for the long term.
Don’t forget to check out our premarket coverage here

Centene

  • The Trade: Centene Corporation (NYSE: CNC) Director Theodore Samuels II bought a total of 7,000 shares at an average price of $71.88. To acquire these shares, it cost around $503.16 thousand.
  • What’s Happening: Centene reported a Q4 FY22 adjusted EPS of $0.86, compared to $1.01 a year ago, slightly ahead of the consensus of $0.85.
  • What Centene Does: Centene is a managed-care organization focused on government-sponsored healthcare plans, including Medicaid, Medicare, and the individual exchanges.
Check This Out: PayPal, Global Payments And 3 Stocks To Watch Heading Into Friday

B. Riley Financial

  • The Trade: B. Riley Financial, Inc. (NASDAQ: RILY) Chairman and Co-CEO Bryant R Riley bought a total 135,923 shares at an average price of $40.18. The insider spent around $5.46 million to buy those shares.
  • What’s Happening: B. Riley Financial, during December, said it expects fourth-quarter FY2022 operating adjusted EBITDA of $90 million - $100 million.
  • What B. Riley Financial Does: B. Riley Financial Inc is a diversified financial services company.
© 2023 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.

Read the original article on Benzinga

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.